SCHEMBL3396969

SCHEMBL3396969

Cc1[nH]c(C)c(-c2c[nH]c(-c3ccc(CN4CCC(F)(F)CC4)cc3)cc2=O)c(=O)c1Cl

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAP3K11 Q16584 3/20 0.39
TNKS O95271 6/20 0.36
PARP1 P09874 2/20 0.35
CNR1 P21554 3/20 0.33
CNR2 P34972 3/20 0.33
BRD4 O60885 1/20 0.33
EZH2 Q15910 1/20 0.33
HRH3 Q9Y5N1 1/20 0.32
GRM2 Q14416 1/20 0.32
ACHE P22303 1/20 0.32
TNIK Q9UKE5 1/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
POLB P06746 1/20 0.32
KMT2A Q03164 1/20 0.32
GSK3B P49841 1/20 0.32
DYRK1A Q13627 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3394483 0.84 TNKS (0.37) MAP3K11TNKSPARP1HRH3GRM2
SCHEMBL3392240 0.79 PRKAB2 (0.36) BRD4MEN1ALDH1A1KMT2A
SCHEMBL4475367 0.79 ADORA2A (0.39) MEN1ALDH1A1KMT2AGSK3B
SCHEMBL4478743 0.79 SLC2A1 (0.42) BRD4MEN1ALDH1A1KMT2A
Hydrochloric Acid SCHEMBL3393361 0.78 DHODH (0.41) GRM2ALDH1A1POLB
SCHEMBL3396963 0.78 MAP3K11 (0.38) MAP3K11CNR1CNR2BRD4HRH3
Hydrochloric Acid SCHEMBL3396774 0.77 GRM2 (0.40) GRM2ACHEALDH1A1
SCHEMBL4483594 0.76 MEN1 (0.31) BRD4MEN1KMT2A
SCHEMBL4481795 0.75 ALDH1A1 (0.43) BRD4MEN1ALDH1A1KMT2AGSK3B
SCHEMBL4474681 0.74 SLC2A1 (0.37) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2246329-A1 4(1H)-pyridinone derivatives and their use as antimalaria agents Glaxo Group Limited (GB) 2010-11-03 EP claimed
EP-2246329-A1 4(1H)-pyridinone derivatives and their use as antimalaria agents Glaxo Group Limited (GB) 2010-11-03 EP disclosed